Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Walid Soussou
CEO/President
walid@wearablesensing.com

Message the company or request a 1:1 meeting here

Neurofeedback is emerging as a viable alternative to pharmacological treatments for mental health issues such as ADHD, anxiety, depression, etc., with a market of $1.1B in 2021 and a 7.9% CAGR. The method’s use of messy gel electroencephalography (EEG) electrodes in up to 40 1-hour long in-clinic sessions leads to high rates of patient attrition and hinders scalability. Wearable Sensing (WS) is commercializing high-fidelity, easy-to-use, and comfortable dry electrode EEG headsets that have been enthusiastically adopted by the neurofeedback community. WS will leverage this technology to create BRAINGYM, a neurofeedback solution that consist of: 1) an FDA-approved headset with in-clinic and at-home use designs, 2) integrated Virtual Reality (VR), and 3) an intuitive cloud-based neurofeedback software with patient and physician user portals. BRAINGYM will revolutionize neurofeedback by increasing patient compliance, reducing their costs, and enabling practitioners to treat more patients.

Pitch Video

Slide Deck